Treatment with neutralizing monoclonal antibody safe and yield positive outcomes in COVID-19 patients: JAMA Medha Baranwal2 May 2023 5:00 AM GMTUSA: Treating COVID-19 patients with neutralizing monoclonal antibody (nMAb) is safe and is associated with a reduction in hospitalization, visits to...
Medical Bulletin 12/December/2022 Isra Zaman12 Dec 2022 8:45 AM GMTHere are the top medical news for the day:Lasting improvements in urinary incontinence by weight-loss surgeryUrinary incontinence is a common...
Monoclonal antibody therapy treatment for moderate to severe atopic dermatitis shows promise: Mount Sinai Research Isra Zaman12 Dec 2022 4:00 AM GMTEczema, also known as atopic dermatitis, is a disorder that results in dry, itchy, and inflamed skin. Although it can happen to anyone, it is more...
Monoclonal antibody treatment for COVID-19 stands safe in pregnancy: Study Dr. Kamal Kant Kohli28 Nov 2022 4:15 AM GMTPennsylvania : A single-center study published in Annals of Internal Medicine found that monoclonal antibody therapy for COVID-19 was safe to use...
CDSCO panel approves GSK pharma's protocol amendment proposal for Mepolizumab Powder for Solution for Injection Dr. Divya Colin20 Nov 2022 9:45 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major GSK...
Anifrolumab promising for patients with moderate to severe lupus: reveals Longest SLE trial Dr. Kamal Kant Kohli17 Nov 2022 2:30 PM GMTUSA: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement ranging from mild to life-threatening...
Tezepelumab plus allergy shots significantly lower symptoms in allergic rhinitis caused by cat allergens Dr. Kamal Kant Kohli10 Nov 2022 4:00 AM GMTResearchers have found in a new study that a combination of Tezepelumab and allergen Immunotherapy significantly lowers symptoms in allergic...
Monoclonal antibody may help prevent malaria infection in endemic region Dr. Kamal Kant Kohli9 Nov 2022 2:45 PM GMTOne dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali,...
Sotrovimab effective treatment option for COVID-19 infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli25 Oct 2022 12:30 PM GMTSPAIN: According to research published in Clinical Kidney Journal, the monoclonal antibody sotrovimab can be safely utilized in kidney transplant...
Tildrakizumab therapy proves beneficial for Plaque Psoriasis Dr. Kamal Kant Kohli3 Oct 2022 2:30 PM GMTITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published...
Monoclonal antibody mepolizumab reduces asthma exacerbations among urban youth: Lancet Dr. Kamal Kant Kohli15 Sep 2022 6:00 AM GMTResearchers have found in a National Institutes of Health clinical trial that Monoclonal antibody mepolizumab, reduces asthma exacerbations among...
Olokizumab Outperforms Placebo in RA patients on maintenance Methotrexate: NEJM Dr. Kamal Kant Kohli29 Aug 2022 2:30 AM GMTVIENNA: Patients with rheumatoid arthritis taking maintenance methotrexate respond better to olokizumab than to a placebo and non-inferior to...
